These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33441564)
1. Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection. Liu Y; Hur J; Chan WKB; Wang Z; Xie J; Sun D; Handelman S; Sexton J; Yu H; He Y Sci Data; 2021 Jan; 8(1):16. PubMed ID: 33441564 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology. He Y; Yu H; Huffman A; Lin AY; Natale DA; Beverley J; Zheng L; Perl Y; Wang Z; Liu Y; Ong E; Wang Y; Huang P; Tran L; Du J; Shah Z; Shah E; Desai R; Huang HH; Tian Y; Merrell E; Duncan WD; Arabandi S; Schriml LM; Zheng J; Masci AM; Wang L; Liu H; Smaili FZ; Hoehndorf R; Pendlington ZM; Roncaglia P; Ye X; Xie J; Tang YW; Yang X; Peng S; Zhang L; Chen L; Hur J; Omenn GS; Athey B; Smith B J Biomed Semantics; 2022 Oct; 13(1):25. PubMed ID: 36271389 [TBL] [Abstract][Full Text] [Related]
3. CIDO ontology updates and secondary analysis of host responses to COVID-19 infection based on ImmPort reports and literature. Huffman A; Masci AM; Zheng J; Sanati N; Brunson T; Wu G; He Y J Biomed Semantics; 2021 Aug; 12(1):18. PubMed ID: 34454610 [TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum coronavirus antiviral drug discovery. Totura AL; Bavari S Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247 [TBL] [Abstract][Full Text] [Related]
6. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective. Nile SH; Nile A; Jalde S; Kai G Food Chem Toxicol; 2021 Aug; 154():112333. PubMed ID: 34118347 [TBL] [Abstract][Full Text] [Related]
8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
9. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167 [TBL] [Abstract][Full Text] [Related]
10. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
11. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS. Mishra J; Prasun C; Sahoo PK; Nair MS Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095 [TBL] [Abstract][Full Text] [Related]
13. [Small molecular agents against MERS-CoV infection]. Zeng XY; Lu L; Jiang SB; Liu SW Yao Xue Xue Bao; 2015 Dec; 50(12):1520-6. PubMed ID: 27169271 [TBL] [Abstract][Full Text] [Related]
14. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Khare P; Sahu U; Pandey SC; Samant M Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. Wang S; Li W; Hui H; Tiwari SK; Zhang Q; Croker BA; Rawlings S; Smith D; Carlin AF; Rana TM EMBO J; 2020 Nov; 39(21):e106057. PubMed ID: 32944968 [TBL] [Abstract][Full Text] [Related]
18. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease. Akaji K; Konno H Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349 [TBL] [Abstract][Full Text] [Related]
19. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection. Krishna G; Pillai VS; Veettil MV Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174 [TBL] [Abstract][Full Text] [Related]
20. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells. Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]